Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
680 | 3099 | 51.7 | 95% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NOTCH | Author keyword | 152 | 21% | 20% | 632 |
2 | NOTCH SIGNALING | Author keyword | 81 | 32% | 7% | 208 |
3 | NOTCH1 | Author keyword | 74 | 38% | 5% | 155 |
4 | GAMMA SECRETASE INHIBITOR | Author keyword | 38 | 47% | 2% | 60 |
5 | JAGGED1 | Author keyword | 32 | 46% | 2% | 52 |
6 | NOTCH 1 | Author keyword | 30 | 42% | 2% | 55 |
7 | JAGGED | Author keyword | 25 | 46% | 1% | 41 |
8 | RBP J | Author keyword | 22 | 56% | 1% | 27 |
9 | RO4929097 | Author keyword | 18 | 89% | 0% | 8 |
10 | DELTEX | Author keyword | 16 | 64% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOTCH | 152 | 21% | 20% | 632 | Search NOTCH | Search NOTCH |
2 | NOTCH SIGNALING | 81 | 32% | 7% | 208 | Search NOTCH+SIGNALING | Search NOTCH+SIGNALING |
3 | NOTCH1 | 74 | 38% | 5% | 155 | Search NOTCH1 | Search NOTCH1 |
4 | GAMMA SECRETASE INHIBITOR | 38 | 47% | 2% | 60 | Search GAMMA+SECRETASE+INHIBITOR | Search GAMMA+SECRETASE+INHIBITOR |
5 | JAGGED1 | 32 | 46% | 2% | 52 | Search JAGGED1 | Search JAGGED1 |
6 | NOTCH 1 | 30 | 42% | 2% | 55 | Search NOTCH+1 | Search NOTCH+1 |
7 | JAGGED | 25 | 46% | 1% | 41 | Search JAGGED | Search JAGGED |
8 | RBP J | 22 | 56% | 1% | 27 | Search RBP+J | Search RBP+J |
9 | RO4929097 | 18 | 89% | 0% | 8 | Search RO4929097 | Search RO4929097 |
10 | DELTEX | 16 | 64% | 1% | 16 | Search DELTEX | Search DELTEX |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MAMMALIAN NOTCH | 181 | 79% | 4% | 115 |
2 | DROSOPHILA NOTCH | 141 | 63% | 5% | 141 |
3 | MOUSE NOTCH1 | 83 | 94% | 1% | 30 |
4 | PROTEIN O FUCOSYL TRANSFERASE 1 | 81 | 75% | 2% | 59 |
5 | INTRACELLULAR DOMAIN | 66 | 23% | 8% | 256 |
6 | GAMMA SECRETASE INHIBITORS | 55 | 39% | 4% | 110 |
7 | RBP J | 47 | 53% | 2% | 62 |
8 | BARR VIRUS EBNA2 | 45 | 65% | 1% | 43 |
9 | JAGGED1 | 42 | 50% | 2% | 60 |
10 | DROSOPHILA MASTERMIND | 40 | 77% | 1% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism | 2009 | 899 | 124 | 59% |
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges | 2014 | 38 | 93 | 57% |
Notch signalling: a simple pathway becomes complex | 2006 | 1054 | 131 | 56% |
Notch signaling: switching an oncogene to a tumor suppressor | 2014 | 26 | 126 | 62% |
Notch signalling in solid tumours: a little bit of everything but not all the time | 2011 | 189 | 167 | 59% |
Therapeutic modulation of Notch signalling - are we there yet? | 2014 | 27 | 283 | 56% |
Notch Signaling: The Core Pathway and Its Posttranslational Regulation | 2009 | 322 | 131 | 60% |
Notch Signaling in the Immune System | 2010 | 161 | 124 | 72% |
Notch signaling: simplicity in design, versatility in function | 2011 | 164 | 321 | 48% |
Notch inhibitors for cancer treatment | 2013 | 39 | 252 | 72% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED GENET DEV BIOL | 6 | 23% | 0.8% | 24 |
2 | PROGRAM STEM CELL DEV BIOL | 4 | 75% | 0.1% | 3 |
3 | MOL BIOL OE5250 | 4 | 56% | 0.2% | 5 |
4 | EMBRYOGENESIS ORGANOGENESIS | 3 | 50% | 0.1% | 4 |
5 | UNITE SIGNALISAT MOL ACTIVAT CELLULAIRE | 2 | 25% | 0.3% | 8 |
6 | RADIOTHER Y MAASTRO | 2 | 67% | 0.1% | 2 |
7 | CELL THER Y TRANSPLANTAT MED | 2 | 10% | 0.6% | 20 |
8 | CLIN EXPT HEMATOL | 2 | 18% | 0.3% | 10 |
9 | MOL CELLULAR BIOCHEM PROGRAM | 1 | 38% | 0.1% | 3 |
10 | ADV CARDIOVASC IMAGING ANAL | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000183012 | ACHAETE SCUTE//GENET 240//ENHANCER OF SPLIT |
2 | 0.0000148168 | DELTA LIKE LIGAND 4//DLL4//ARTERIAL VENOUS DIFFERENTIATION |
3 | 0.0000141632 | ENDOCRINE SURG S//ACHAETE SCUTE COMPLEX LIKE 1//CLIN SCI H4 750 |
4 | 0.0000097375 | FBXW7//FBW7//HCDC4 |
5 | 0.0000095805 | SOMITOGENESIS//SEGMENTATION CLOCK//SPONDYLOCOSTAL DYSOSTOSIS |
6 | 0.0000081908 | PAX5//EXPT HEMATOPOIESIS UNIT//EBF |
7 | 0.0000079431 | ALAGILLE SYNDROME//ARTERIOHEPATIC DYSPLASIA//ALAGILLES SYNDROME |
8 | 0.0000059981 | CADASIL//NOTCH3//NOTCH3 GENE |
9 | 0.0000057796 | NEUROBLAST//NUMB//PROSPERO |
10 | 0.0000056347 | DLK1//PREF 1//FETAL ANTIGEN 2 |